A Novel Monoclonal Antibody Targets Mucin1 and Attenuates Growth in Pancreatic Cancer Model
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Novel Monoclonal Antibody Targets Mucin1 and Attenuates Growth in Pancreatic Cancer Model
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 7, Pages 2004
Publisher
MDPI AG
Online
2018-07-09
DOI
10.3390/ijms19072004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gomisin G Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing AKT Phosphorylation and Decreasing Cyclin D1
- (2018) Sony Maharjan et al. Biomolecules & Therapeutics
- A Mucin1 C-terminal Subunit-directed Monoclonal Antibody Targets Overexpressed Mucin1 in Breast Cancer
- (2018) Guang Wu et al. Theranostics
- Cancer of the Pancreas: Are we Making Progress? A Review of Studies in the US Oncology Research Network
- (2017) Thomas Cartwright et al. Cancer Control
- Anti-metastatic effect of the TM4SF5-specific peptide vaccine and humanized monoclonal antibody on colon cancer in a mouse lung metastasis model
- (2016) Guang Wu et al. Oncotarget
- Monoclonal Antibody Targeting of the Cell Surface Molecule TM4SF5 Inhibits the Growth of Hepatocellular Carcinoma
- (2014) S. Kwon et al. CANCER RESEARCH
- MUC1: a multifaceted oncoprotein with a key role in cancer progression
- (2014) Sritama Nath et al. TRENDS IN MOLECULAR MEDICINE
- Mucins in pancreatic cancer and its microenvironment
- (2013) Sukhwinder Kaur et al. Nature Reviews Gastroenterology & Hepatology
- MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes
- (2013) S Nath et al. Oncogenesis
- Mucin-based Targeted Pancreatic Cancer Therapy
- (2012) Maria P. Torres et al. CURRENT PHARMACEUTICAL DESIGN
- MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches
- (2012) D W Kufe ONCOGENE
- Immunotherapy updates in pancreatic cancer: are we there yet?
- (2012) Krishna Soujanya Gunturu et al. Therapeutic Advances in Medical Oncology
- Anti-MUC1 antibody inhibits EGF receptor signaling in cancer cells
- (2011) Akinori Hisatsune et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells
- (2011) J Merlin et al. ONCOGENE
- Anti-MUC1 Monoclonal Antibody (C595) and Docetaxel Markedly Reduce Tumor Burden and Ascites, and Prolong Survival in an in vivo Ovarian Cancer Model
- (2011) Li Wang et al. PLoS One
- EGFR Signaling and Drug Discovery
- (2010) Georg Lurje et al. ONCOLOGY
- Significance of mucin expression in pancreatobiliary neoplasms
- (2009) Suguru Yonezawa et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Induction of IgG antibodies to MUC1 and survival in patients with epithelial ovarian cancer
- (2008) Angèle L.M. Oei et al. INTERNATIONAL JOURNAL OF CANCER
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started